SG11202005231RA - Spray-dried thrombin and methods of using and making spray-dried thrombin - Google Patents

Spray-dried thrombin and methods of using and making spray-dried thrombin

Info

Publication number
SG11202005231RA
SG11202005231RA SG11202005231RA SG11202005231RA SG11202005231RA SG 11202005231R A SG11202005231R A SG 11202005231RA SG 11202005231R A SG11202005231R A SG 11202005231RA SG 11202005231R A SG11202005231R A SG 11202005231RA SG 11202005231R A SG11202005231R A SG 11202005231RA
Authority
SG
Singapore
Prior art keywords
spray
dried thrombin
methods
making
thrombin
Prior art date
Application number
SG11202005231RA
Other languages
English (en)
Inventor
Alexander Wesley Scott
Paul Jeffrey Sanders
Alyssa Sanders
Adam Christopher Mercer
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of SG11202005231RA publication Critical patent/SG11202005231RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202005231RA 2017-12-29 2018-12-20 Spray-dried thrombin and methods of using and making spray-dried thrombin SG11202005231RA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762611963P 2017-12-29 2017-12-29
US201862771936P 2018-11-27 2018-11-27
PCT/US2018/066838 WO2019133440A1 (en) 2017-12-29 2018-12-20 Spray-dried thrombin and methods of using and making spray-dried thrombin

Publications (1)

Publication Number Publication Date
SG11202005231RA true SG11202005231RA (en) 2020-07-29

Family

ID=65024106

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005231RA SG11202005231RA (en) 2017-12-29 2018-12-20 Spray-dried thrombin and methods of using and making spray-dried thrombin

Country Status (12)

Country Link
US (1) US11583610B2 (https=)
EP (1) EP3731885B1 (https=)
JP (1) JP2021508507A (https=)
KR (1) KR20200105680A (https=)
CN (1) CN111787958A (https=)
AU (1) AU2018396037A1 (https=)
BR (1) BR112020011034A2 (https=)
CA (1) CA3083064A1 (https=)
ES (1) ES3058243T3 (https=)
MX (1) MX2020006856A (https=)
SG (1) SG11202005231RA (https=)
WO (1) WO2019133440A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12343385B2 (en) 2021-11-29 2025-07-01 Baxter International Inc. Hemostat reconstitution methods and devices
CN118785918A (zh) 2021-12-23 2024-10-15 广州倍绣生物技术有限公司 喷雾干燥的凝血酶

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
DE19859611C2 (de) * 1998-12-23 2003-07-03 Aventis Behring Gmbh Fibrinklebergranulat und Verfahren zu dessen Herstellung
ES2682302T3 (es) 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
JP5973997B2 (ja) 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血用組成物を作製するためのプロセス
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) * 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法

Also Published As

Publication number Publication date
KR20200105680A (ko) 2020-09-08
ES3058243T3 (en) 2026-03-09
BR112020011034A2 (pt) 2020-11-17
US11583610B2 (en) 2023-02-21
CA3083064A1 (en) 2019-07-04
MX2020006856A (es) 2020-08-24
JP2021508507A (ja) 2021-03-11
CN111787958A (zh) 2020-10-16
WO2019133440A1 (en) 2019-07-04
AU2018396037A1 (en) 2020-06-18
EP3731885A1 (en) 2020-11-04
US20210379240A1 (en) 2021-12-09
EP3731885B1 (en) 2025-10-08

Similar Documents

Publication Publication Date Title
IL286316A (en) New micro-dystrophins and related method of use
SG11202002902SA (en) Structurally-colored articles and methods of making and using structurally-colored articles
GB201512955D0 (en) Receiver and method of receiving
EP3240799A4 (en) S-alkylated hepcidin peptides and methods of making and using thereof
ZA201805000B (en) Resilient unit and method of manufacture
IL264613B (en) Hemostatic preparations and methods for their preparation
GB2555248B (en) Artificial placenta and methods of preparation
GB201507188D0 (en) Resilient unit and method of manufacture
GB201512949D0 (en) Receiver and method of receiving
IL270792A (en) Methods for the preparation and use of PDE9 inhibitors
EP3136879A4 (en) Concentrated protein compositions and methods of their making and use
GB201512952D0 (en) Receiver and method of receiving
SG10202102552RA (en) Adsorbents and methods of making and using adsorbents
IL251828B (en) Hemostatic agents with improved properties and methods for their preparation
GB201512953D0 (en) Receiver and method of receiving
IL249662A0 (en) Tampon and method for preparation
EP3274261A4 (en) Bags and methods of making bags
GB2558025B (en) Particulates and methods of making particulates
EP3221386A4 (en) Polyphosphate hydrogels and methods of making and using thereof
EP3448375C0 (en) BENZOYLGLYCINE DERIVATIVES AND METHODS OF PRODUCING AND USING SUCH DERIVATIVES
EP3282857A4 (en) Human milk compositions and methods of making and using same
GB2559482B (en) Superhard constructions and methods of making same
IL247840B (en) Sildenafil solutions and methods for their preparation and use
IL257027A (en) Loudspeaker and method of its manufacture
EP3253396A4 (en) Probiotic compositions and methods of use